Compositions for delivering parathyroid hormone and calcitonin
AssigneeEmisphere Technologies, Inc.
InventorMichael M. Goldberg
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition comprising a delivery agent, parathyroid hormone, and calcitonin. This composition exhibits increased delivery of parathyroid hormone and/or calcitonin and is useful for the treatment of osteoporosis. The composition also permits simultaneous oral delivery of parathyroid hormone and calcitonin. The composition of the present invention may be formulated into a dosage unit form, such as an oral dosage unit form. The invention also provides a method for administering parathyroid hormone and calcitonin to an animal in need thereof by administering the composition of the present invention.
Claims12
A composition comprising a delivery agent, parathyroid hormone, and calcitonin.
An oral dosage unit form comprising (a) a delivery agent, (b) parathyroid hormone, (c) calcitonin, and (d) an excipient, a diluent, a disintegrant, a lubricant, a plasticizer, a colorant, a dosing vehicle, or any combination thereof.
A method of treating osteoporosis comprising administering an effective amount of a delivery agent, parathyroid hormone, and calcitonin.
A method for orally administering an effective dose of PTH comprising orally coadministering to a patient in need of PTH an effective amount of a PTH and an effective amount of a calcitonin.
12-43. (canceled)
Dependencies are inferred from the claim text.